B. Riley Securities Reiterates Buy Rating on Diversified Healthcare Trust
B. Riley Securities maintains its Buy rating on Diversified Healthcare Trust, setting a target price of $11, a 21.82% upside from the current price.
Key Points
- B. Riley Securities reiterated its Buy rating for Diversified Healthcare Trust, setting a price target of $11 on June 9, 2026.
- B. Riley Securities's $11 price target implies 21.82% upside from Diversified Healthcare Trust's ($DHC) current $9.03 share price.
- Shares of NasdaqGS:DHC are trading around $8.85, with a market cap of $2.19 billion and a 52-week range between $3.18 and $9.14.
- Insiders at DHC have been active, with CEO Jennifer Francis buying 60,000 shares and CFO Matthew Brown selling shares in 2023.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 9, 2026, B. Riley Securities reiterated its Buy rating for Diversified Healthcare Trust, a real estate investment trust trading under the ticker DHC on the NasdaqGS. The firm set a price target of $11, indicating confidence in the company's future prospects.
Other Institutional Activity in Diversified Healthcare Trust
BlackRock, Inc. increased its holdings in Diversified Healthcare Trust by 880,011 shares, ending with 23,878,687 shares valued at about $158.6 million. In contrast, Flat Footed LLC and Silver Point Capital L.P. maintained their positions, holding 23,487,002 and 15,504,810 shares respectively. Vanguard Capital Management LLC took a new position with 9,599,703 shares worth approximately $63.7 million, while State Street Corp added 2,339,324 shares, bringing its total to 8,986,912 shares valued at $59.7 million.
Diversified Healthcare Trust Stock Up 18.0%
Shares of NasdaqGS:DHC traded near $8.85. Diversified Healthcare Trust has a market cap of $2.19 billion. The stock has a 52-week low of $3.18 and a high of $9.14, with a 50-day moving average of $8.02 and a 200-day moving average of $5.93. The company has a high beta of 2.293, indicating significant volatility relative to the market.
Recent Earnings
Diversified Healthcare Trust reported revenue of approximately $1.52 billion, with a revenue decline of 5.3%. The company is not currently profitable, posting a net margin of -21.1% and a return on equity of -17.9%. The next earnings report is expected on May 4, 2026.
Insider Buying and Selling at Diversified Healthcare Trust
Insiders at Diversified Healthcare Trust have been active. On September 13, 2023, CEO Jennifer Francis purchased 60,000 shares, while CFO Matthew Brown sold 9,711 shares on September 16, 2025. These transactions were not part of planned trading programs.
Analysts Set New Price Targets
On June 9, 2026, B. Riley Securities maintained its Buy rating with an $11 price target. Earlier, on June 3, 2026, Maxim Group also maintained a Buy rating, setting a target of $10.5. The consensus among analysts is a Buy, with a mean target price of $9.38 based on four analyst opinions.
About Diversified Healthcare Trust
Diversified Healthcare Trust, headquartered in Newton, MA, is a real estate investment trust focused on healthcare properties across the United States. The company aims to diversify its portfolio across various healthcare services and property types. As of March 31, 2026, it owned 285 properties in 33 states, including senior living units and medical office buildings. DHC is managed by The RMR Group, a major asset management company.
Bottom Line
B. Riley Securities' reiteration of its Buy rating for Diversified Healthcare Trust highlights continued positive sentiment among analysts. The stock's current trading price and market cap reflect its position within the healthcare REIT sector. Investors should note that 13F filings are backward-looking and may not represent current positions.
Get Diversified Healthcare Trust alerts
New 13F filings, insider trades, and analyst moves on $DHC, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.